$XLV going to outperform $SPY (5/5)
Conviction: 5/5
Health Care (
XLV) is looking very attractive relative to S&P 500 (
SPY), just bounced off of long-term (2022) support on a relative basis.
RSI-M at oversold levels (obviously), while RSI-W seems to have put in a bullish divergence?
Let's see which channel wins, but I think long-term one is stronger.
Health Care (
XLV) is looking very attractive relative to S&P 500 (SPY), just bounced off of long-term (2022) support on a relative basis.RSI-M at oversold levels (obviously), while RSI-W seems to have put in a bullish divergence?
Let's see which channel wins, but I think long-term one is stronger.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.